Cargando…
Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
When making decisions about adjuvant chemotherapy for early-stage breast cancer, costs and benefits of treatment should be carefully weighed. In this process, patients' preferences are of major importance. The objectives of the present study were: (1) to determine the minimum benefits that pati...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2001
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363690/ https://www.ncbi.nlm.nih.gov/pubmed/11401308 http://dx.doi.org/10.1054/bjoc.2001.1836 |